Marfan Syndrome - Acute Aortic Dissection Due to Giant Aortic Aneurysm
- PMID: 30595862
- PMCID: PMC6286717
- DOI: 10.12865/CHSJ.43.01.15
Marfan Syndrome - Acute Aortic Dissection Due to Giant Aortic Aneurysm
Abstract
Marfan syndrome is a genetic disorder with an estimated prevalence of 1/5000 births. Clinical manifestation and disease progress can vary among individuals affected therefore serial follow-up examinations are mandatory in order to prevent serious complications.We report a case of giant proximal aorta aneurysm with associated aortic dissection in a young patient with Marfan syndrome who neglected medical advice to undergo periodic medical evaluation.Given the fact that clinical manifestations may differ among patients making prediction of disease progression very difficult, the patient with Marfan syndrome should be carefully monitored.
Keywords: Aorta; Marfan Syndrome; aneurysm; dissecting.
Figures



Similar articles
-
Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.Verh K Acad Geneeskd Belg. 2009;71(6):335-71. Verh K Acad Geneeskd Belg. 2009. PMID: 20232788 Review.
-
[Cardiovascular manifestations and treatment in Marfan syndrome].Anadolu Kardiyol Derg. 2005 Mar;5(1):46-52. Anadolu Kardiyol Derg. 2005. PMID: 15755703 Review. Turkish.
-
Aortic dissection in patients with Marfan syndrome based on the IRAD data.Ann Cardiothorac Surg. 2017 Nov;6(6):633-641. doi: 10.21037/acs.2017.10.03. Ann Cardiothorac Surg. 2017. PMID: 29270375 Free PMC article.
-
Imaging-Based 4D Aortic Pressure Mapping in Marfan Syndrome Patients: A Matched Case-Control Study.Ann Thorac Surg. 2020 May;109(5):1434-1440. doi: 10.1016/j.athoracsur.2019.08.048. Epub 2019 Sep 27. Ann Thorac Surg. 2020. PMID: 31568745
-
Imaging of the Postsurgical Aorta in Marfan Syndrome.Curr Treat Options Cardiovasc Med. 2018 Aug 27;20(10):80. doi: 10.1007/s11936-018-0675-2. Curr Treat Options Cardiovasc Med. 2018. PMID: 30146656 Review.
References
-
- Fusar-Poli P, Klersy C, Stramesi F, Callegari A, Arbustini E, Politi P. Determinants of quality of life in Marfan syndrome. Psychosomatics. 2008;49(3):243–248. - PubMed
-
- Kainulainen K, Karttunen L, Puhakka L, Sakai L, Peltonen L. Mutations in the fibrillin gene responsible for dominant ectopialentis and neonatal Marfan syndrome. Nat Genet. 1994;6:64–69. - PubMed
-
- Dietz HC, Loeys B, Carta L, Ramirez F. Recent progress towards a molecular understanding of Marfan syndrome. Am J Med Genet C Semin Med Genet. 2005;139C(1):4–9. - PubMed
-
- Ramirez F, Dietz HC. Marfan syndrome: from molecular pathogenesis to clinical treatment. CurrOpin Genet Dev. 2007;17(3):252–258. - PubMed
-
- Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, Callewaert B, Arbustini E, Mayer K, Arslan-Kirchner M, Kiotsekoglou A, Comeglio P, Marziliano N, Dietz HC, Halliday D, Beroud C, Bonithon-Kopp C, Claustres M, Muti C, Plauchu H, Robinson PN, Adès LC, Biggin A, Benetts B, Brett M, Holman KJ, De Backer J, Coucke P, Francke U, De Paepe A, Jondeau G, Boileau C. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet. 2007;81(3):454–466. - PMC - PubMed
LinkOut - more resources
Full Text Sources